Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.

Hsu MA, Hirdler JB, Lavoie R, Orme JJ, Hawthorne L, Ruegg CL, Dodgson J, Dong H, Park SS, Lucien F

DOI: 10.2147/ijn.s607073
Published: 2026
Container: International journal of nanomedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/ijn.s607073,
  title = {Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.},
  author = {Hsu MA and Hirdler JB and Lavoie R and Orme JJ and Hawthorne L and Ruegg CL and Dodgson J and Dong H and Park SS and Lucien F},
  year = {2026},
  journal = {International journal of nanomedicine},
  doi = {10.2147/ijn.s607073},
  url = {https://doi.org/10.2147/ijn.s607073}
}

RIS

TY  - JOUR
TI  - Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.
AU  - Hsu MA
AU  - Hirdler JB
AU  - Lavoie R
AU  - Orme JJ
AU  - Hawthorne L
AU  - Ruegg CL
AU  - Dodgson J
AU  - Dong H
AU  - Park SS
AU  - Lucien F
PY  - 2026
JO  - International journal of nanomedicine
DO  - 10.2147/ijn.s607073
UR  - https://doi.org/10.2147/ijn.s607073
ER  -

APA

MA, H., JB, H., R, L., JJ, O., L, H., CL, R., J, D., H, D., SS, P., & F, L. (2026). Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.. International journal of nanomedicine. https://doi.org/10.2147/ijn.s607073

Source records

pubmed · retrieved 2026-09-25T12:07:56.183Z